OXFORD TCE & RAWLING RD MEDICAL GROUP
1 OXFORD TERRACE, BENSHAM, GATESHEAD
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 37 | 39 | 94.9% | |
| HF 4 | 2011 | 56 | 57 | 98.2% | |
| HF 4 | 2012 | 57 | 57 | 100.0% | |
| HF 4 | 2013 | 62 | 62 | 100.0% | |
| HF004 | 2014 | 65 | 66 | 98.5% | |
| HF004 | 2015 | 67 | 68 | 98.5% | |
| HF004 | 2016 | 75 | 75 | 100.0% | |
| HF004 | 2017 | 87 | 89 | 97.8% | |
| HF004 | 2018 | 88 | 90 | 97.8% | |
| HF004 | 2019 | 99 | 100 | 99.0% | |
| HF004 | 2020 | 102 | 103 | 99.0% | |
| HF006 | 2021 | 138 | 140 | 98.6% | |
| HF006 | 2022 | 150 | 153 | 98.0% | |
| HF006 | 2023 | 162 | 164 | 98.8% |
